David Apelian

2013 - Achillion Pharmaceuticals

In 2013, David Apelian earned a total compensation of $2.2M as Executive Vice President and Chief Medical Officer at Achillion Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$100,100
Option Awards$1,807,634
Salary$256,667
Other$10,726
Total$2,175,127

Apelian received $1.8M in option awards, accounting for 83% of the total pay in 2013.

Apelian also received $100.1K in non-equity incentive plan, $256.7K in salary and $10.7K in other compensation.

Rankings

In 2013, David Apelian's compensation ranked 3,619th out of 12,286 executives tracked by ExecPay. In other words, Apelian earned more than 70.5% of executives.

ClassificationRankingPercentile
All
3,619
out of 12,286
71st
Division
Manufacturing
1,226
out of 4,612
73rd
Major group
Chemicals And Allied Products
333
out of 1,466
77th
Industry group
Drugs
233
out of 1,160
80th
Industry
Pharmaceutical Preparations
191
out of 890
79th
Source: SEC filing on April 15, 2016.

Apelian's colleagues

We found five more compensation records of executives who worked with David Apelian at Achillion Pharmaceuticals in 2013.

2013

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2013

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

2013

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2013

Gautam Shah

Achillion Pharmaceuticals

Former Executive Vice President and Chief Compliance Officer

2013

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

News

In-depth

You may also like